BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» Other news to note for April 4, 2023
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 4, 2023
April 4, 2023
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alaunos, Arbutus, Arrowhead, Beactica, Biontech, Briacell, Diamyd, Enzyvant, Forcefield, Freeline, Genevant, Gri, GSK, Histogram, Indivumed, Liquidia, Medigene, Metabolon, Myovant, Oncternal, Oscotec, Pfizer, Precigen, Sumitomo, Sumitovant, Tonix, Urovant, Vallon, VBI.
BioWorld
Briefs
Other news to note
Coronavirus